In this study, we found that serum YKL-40 was significantly elevated than the level in HCC patients compared to healthy controls (P<0.001),which provide additional evidence that elevated serum YKL-40 may play a role in cancer cell proliferation, survival, invasiveness and in the regulation of cell-matrix interactions [21]. The gene discussed is CHI3L1; the disease is hepatocellular carcinoma.